May 15 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 252.33 250.60 264.60 131.10
(+0.7 pct) (+3.4 pct) (+4.9 pct) (+5.5 pct)
Operating 2.37 7.01 7.00 3.10
(-66.2 pct) (+66.6 pct) (+195.2 pct) (+56.9 pct)
Recurring 4.66 7.62 7.10 3.30
(-38.8 pct) (+40.9 pct) (+52.4 pct) (+15.6 pct)
Net
Net loss 2.16 971 mln 7.50 2.30
(-62.5 pct) (+1286.2 pct)
EPS loss 52.27 yen 22.61 yen 174.54 yen 53.52 yen
EPS Diluted 22.46 yen
Ann Div 35.00 yen 32.50 yen 35.00 yen
-Q2 Div 17.50 yen 15.00 yen 17.50 yen
-Q4 Div 17.50 yen 17.50 yen 17.50 yen
NOTE - Xebio Holdings Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T